Shares of Replimune Group, Inc. (REPL) have gained 0.7% over the past four weeks to close the last trading session at $7.76, but there could still be a solid upside left in the stock if short-term ...
Replimune Group beat estimated earnings by 7.000000000000001%, reporting an EPS of $-0.77 versus an estimate of $-0.83. Revenue was down $0 from the same period last year. The company missed on EPS by ...
Julia Hawley is a full-time writer focusing on investing. She combines her writing skills with her experience in personal wealth management. Katie Miller is a consumer financial services expert. She ...
Access detailed historical stock prices, including daily closing prices, for REPL. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
This page serves to provide important NSF and NIH updates and guide/policy notices relevant to UB faculty and staff for proposal submissions and award administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results